Publications by authors named "Estivaliz Arizel De la O-Espinoza"
Article Synopsis
- The study aimed to assess lung function and asthma control in patients with Non-Exacerbated Respiratory Disease (N-ERD) over three years, following GINA guidelines.
- At baseline, N-ERD patients showed better lung function and required lower doses of inhaled corticosteroids compared to traditional asthma patients, who relied more on oral corticosteroids.
- By the end of the follow-up, the lung function of traditional asthma patients improved significantly, leading to similar asthma control levels in both groups, but one-third of N-ERD patients continued needing additional medications to maintain control.
Background: The Wiskott-Aldrich syndrome is a combined immunodeficiency associated with a syndrome linked to the X chromosome, which is characterized by eczema, recurrent infections, and thrombocytopenia. Other manifestations include autoimmune disorders such as hemolytic anemia or thrombocytopenic purpura mediated by the immune system, increased susceptibility to malignant tumors, including lymphoma or leukemia.
Clinical Case: A 7-year-old male patient with a diagnosis of Wiskott-Aldrich syndrome who was treated with intravenous gamma globulin, antimicrobial prophylaxis with trimethoprim/sulfamethoxazole, and fluconazole, as well as with prednisone and cyclosporine due to hemolytic anemia and uveitis.